Measuring Osteoporosis Quality: The Work of the Joint Commission
- PDF / 88,723 Bytes
- 3 Pages / 595.276 x 790.866 pts Page_size
- 89 Downloads / 179 Views
QUALITY OF CARE IN OSTEOPOROSIS (SL SILVERMAN, SECTION EDITOR)
Measuring Osteoporosis Quality: The Work of the Joint Commission Stuart Silverman
Published online: 28 September 2013 # Springer Science+Business Media New York 2013
Abstract Recognizing the significant impact of osteoporosis, The Joint Commission has worked since 2005 to develop performance measures in osteoporosis across the care continuum. This work has led to the development of 3 measures, which may be used at any time to meet hospital quality improvement goals. Plans are in place to submit to the National Quality Forum for endorsement as national consensus standards. The measures were developed under the guidance of a 12 member Technical Advisory Panel. Keywords Osteoporosis quality . The Joint Commission
The Joint Commission The Joint Commission, formerly The Joint Commission on Accreditation of Healthcare Organizations and previous to that The Joint Commission on Accreditation of Hospitals, is a United States-based independent, not-for-profit organization, which accredits and certifies more than 20,000 health care organizations and programs in the United States. Joint Commission accreditation and certification is recognized nationwide as a symbol of quality that reflects an organization’s commitment to meeting certain performance standards. The mission of The Joint Commission is to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations, and inspiring them to excel in providing safe and effective care of the highest quality and value. Its vision is that all people will
S. Silverman (*) Rheumatology Division, Department of Medicine, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA and the OMC Clinical Research Center, Los Angeles, CA 90095, USA e-mail: [email protected]
always experience the safest, highest quality, best-value health care across all settings.
The Osteoporosis Quality Initiative In 2005, The Joint Commission received funding from the National Pharmaceutical Council to develop a monograph to be distributed free of charge that addressed Osteoporosis Prevention and Treatment. Recognizing the significant impact of this under-treated disease, The Joint Commission embarked on a multi-year project, under the guidance of a Technical Advisory Panel (TAP) to develop evidence-based performance measures across the care continuum, and to publish the monograph [1]. The 12 participants of the TAP were multispecialty including: Laura Bachrach in pediatric endocrinology; Arlene Berman representing the American Association of Retired Persons (AARP); Douglas Kiel representing the American Geriatric Society; Marguerite Koster representing Kaiser Permanente; Joseph Lane representing the American Academy of Orthopedic Surgeons; Joan Lappe representing the American Nurses Association; James Liu representing the American College of Obstetrics and Gynecology; Eric MacLaughlin representing the American Society of Health System Pharmacists; Steven Petak rep
Data Loading...
